Literature DB >> 11745995

Evidence of decreased risk of cancer in individuals with fragile X.

S Schultz-Pedersen1, H Hasle, J H Olsen, U Friedrich.   

Abstract

The occurrence of cancer was studied in a cohort of 223 persons with fragile X syndrome, based on information from the Danish Cytogenetic Registry and the Danish Cancer Registry. Four cases of cancer were found, (carcinoma of pancreas, urinary bladder, uterus, and rectum). None of these cancer types have been reported in patients with fragile X syndrome previously. Compared with cancer rates in the general population, the standardized incidence ratio (SIR) was decreased to 0.28 (95% confidence interval: 0.1-0.8). The possibility that the expanded trinucleotide repeats in fragile X syndrome protect against cancer is discussed. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2001        PMID： 11745995

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN： 0148-7299


  28 in total

Review 1.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

Review 2.  Approach to the Diagnosis of Overgrowth Syndromes.

Authors:  Mohnish Suri
Journal:  Indian J Pediatr       Date:  2015-12-18       Impact factor: 1.967

Review 3.  Health disparities between women with and without disabilities: a review of the research.

Authors:  Jennifer P Wisdom; Marjorie G McGee; Willi Horner-Johnson; Yvonne L Michael; Elizabeth Adams; Michelle Berlin
Journal:  Soc Work Public Health       Date:  2010-05

4.  Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110β-selective inhibitor.

Authors:  Christina Gross; Gary J Bassell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 5.  Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.

Authors:  Christina Gross; Elizabeth M Berry-Kravis; Gary J Bassell
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

6.  A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response.

Authors:  Roman Alpatov; Bluma J Lesch; Mika Nakamoto-Kinoshita; Andres Blanco; Shuzhen Chen; Alexandra Stützer; Karim J Armache; Matthew D Simon; Chao Xu; Muzaffar Ali; Jernej Murn; Sladjana Prisic; Tatiana G Kutateladze; Christopher R Vakoc; Jinrong Min; Robert E Kingston; Wolfgang Fischle; Stephen T Warren; David C Page; Yang Shi
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

7.  Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome.

Authors:  Hailan Hu; Yi Qin; Genrieta Bochorishvili; Yinghua Zhu; Linda van Aelst; J Julius Zhu
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

8.  Aging in fragile X syndrome.

Authors:  Agustini Utari; Evan Adams; Elizabeth Berry-Kravis; Alyssa Chavez; Felicia Scaggs; Lily Ngotran; Antoniya Boyd; David Hessl; Louise W Gane; Flora Tassone; Nicole Tartaglia; Maureen A Leehey; Randi J Hagerman
Journal:  J Neurodev Disord       Date:  2010-05-12       Impact factor: 4.025

Review 9.  Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Authors:  Mrinmoyee Majumder; Roger H Johnson; Viswanathan Palanisamy
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-02       Impact factor: 8.250

Review 10.  The RNA-binding fragile-X mental retardation protein and its role beyond the brain.

Authors:  Cassandra Malecki; Brett D Hambly; Richmond W Jeremy; Elizabeth N Robertson
Journal:  Biophys Rev       Date:  2020-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.